Skip to content

A study to evaluate the effects of foods containing indigestible dextrin on the blood glucose elevation inhibitory effect Rondomised,double blind, placebo controlled crossover study

A study to evaluate the effects of foods containing indigestible dextrin on the blood glucose elevation inhibitory effect Rondomised,double blind, placebo controlled crossover study - A study to evaluate the effects of foods containing indigestible dextrin on the blood glucose elevation inhibitory effect Rondomised,double blind, placebo controlled crossover study

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000038067
Enrollment
10
Registered
2019-09-20
Start date
2019-09-30
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

healthy individuals

Interventions

Single ingestion of study food Single ingestion of control food

Sponsors

Miura Clinic, Medical Corporation Kanonkai
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: (1) Subjects of men and women aged 20 to 64 (2)Subjects who received a sufficient explanation of the purpose and contents of the study, an ability to consent, a volunteer who volunteered to participate with a good understanding and who agreed to participate in the study

Exclusion criteria

Exclusion criteria: (1) Subjects with a history of diabetes, liver disease, kidney disease, gastrointestinal disease, peripheral vascular disorder, and other serious diseases (2) Subjects who may have allergic symptoms due to ingredients in the test food (3) Subjects with impaired cardiopulmonary function (4) Subjects with abnormal liver and kidney function test values (5) Subjects who have undergone gastrointestinal surgery (6) Subjects with a disease currently being treated (7) Subjects with food and drug allergies (8) Subjects who have a habit of smoking (9) Subjects who play intense sports and are on a diet (10) Subjects taking food, health foods, quasi-drugs, and pharmaceuticals (including OTC and prescription drugs) that may affect the endpoints of the study (11) Subjects who are excessively consuming alcohol or subjects who cannot ban alcohol from 2 days before the test date (12) Subjects who are pregnant or who are scheduled to become pregnant or breastfeeding during the study period (13) Subjects who are or will be participating in other clinical studies at the start of this study (14) Other subjects deemed inappropriate by the investigator

Design outcomes

Primary

MeasureTime frame
Blood glucose Insulin

Countries

Japan

Contacts

Public ContactMakoto Terashima

Oneness Support Co., Ltd. Clinical Trial Division

mterashima@oneness-sup.co.jp0648018917

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026